.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Healthtrust
Mallinckrodt
Citi
Queensland Health
Daiichi Sankyo
US Army
Johnson and Johnson
Medtronic
Express Scripts

Generated: September 20, 2017

DrugPatentWatch Database Preview

Chartwell Rx Company Profile

« Back to Dashboard

What is the competitive landscape for CHARTWELL RX, and what generic and branded alternatives to CHARTWELL RX drugs are available?

CHARTWELL RX has ten approved drugs.



Summary for Applicant: Chartwell Rx

Patents:0
Tradenames:10
Ingredients:10
NDAs:10
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx
MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL090096-002Sep 25, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Rx
PREDNISONE
prednisone
TABLET;ORAL083059-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Rx
MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL090096-001Sep 25, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Rx
MOEXIPRIL HYDROCHLORIDE
moexipril hydrochloride
TABLET;ORAL077536-002Nov 30, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Chartwell Rx
CALCIUM ACETATE
calcium acetate
CAPSULE;ORAL091312-001Jun 1, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Chartwell Rx
MOEXIPRIL HYDROCHLORIDE
moexipril hydrochloride
TABLET;ORAL077536-001Nov 30, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Chartwell Rx
INDOMETHACIN
indomethacin
CAPSULE, EXTENDED RELEASE;ORAL200529-001Nov 30, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Chartwell Rx
PREDNISOLONE
prednisolone
TABLET;ORAL084542-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Rx
PROPYLTHIOURACIL
propylthiouracil
TABLET;ORAL084543-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Rx
GRISEOFULVIN
griseofulvin, microsize
SUSPENSION;ORAL065200-001Mar 2, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Moodys
Dow
US Department of Justice
AstraZeneca
Merck
US Army
QuintilesIMS
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot